1 |
Nobis A, Zalewski D, Samaryn E, Maciejczyk M, Zalewska A, Waszkiewicz N. Urine 3-Nitrotyrosine and Serum HDL as Potential Biomarkers of Depression. J Clin Med 2023;12. [PMID: 36615177 DOI: 10.3390/jcm12010377] [Reference Citation Analysis]
|
2 |
Paus MHJ, van den Heuvel ER, Meddens MJM. Binary disease prediction using tail quantiles of the distribution of continuous biomarkers. Journal of Nonparametric Statistics 2022. [DOI: 10.1080/10485252.2022.2141738] [Reference Citation Analysis]
|
3 |
Li Y, Yue Y, Chen S, Jiang W, Xu Z, Chen G, Zhu Z, Tan L, Yuan Y. Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder. Front Mol Neurosci 2022;15:935031. [DOI: 10.3389/fnmol.2022.935031] [Reference Citation Analysis]
|
4 |
Galvão ACM, Almeida RN, de Sousa Júnior GM, Leocadio-Miguel MA, Palhano-Fontes F, de Araujo DB, Lobão-Soares B, Maia-de-Oliveira JP, Nunes EA, Hallak JEC, Sarris J, Galvão-Coelho NL. Potential biomarkers of major depression diagnosis and chronicity. PLoS One 2021;16:e0257251. [PMID: 34587177 DOI: 10.1371/journal.pone.0257251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
5 |
Jentsch MC, Burger H, Meddens MBM, Beijers L, van den Heuvel ER, Meddens MJM, Schoevers RA. Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics. Int J Mol Sci 2020;21:E3039. [PMID: 32344909 DOI: 10.3390/ijms21093039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
6 |
Fiedorowicz JG. New challenges in the COVID-19 pandemic. J Psychosom Res 2020;133:110123. [PMID: 32339886 DOI: 10.1016/j.jpsychores.2020.110123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|